MANNKIND CORP cotiza a 3.05 USD y tiene una capitalización bursátil de $981M. En los últimos 12 meses ha facturado $394M con un margen de flujo de caja libre del 3.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address various unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney d…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.01 | $-0.02 | $-0.05 |
| Estimado | — | $0.02 | $0.01 | $0.01 |
| Sorpresa | — | -150.0% | -300.0% | -600.0% |
| Métrica | MNKD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 92.3% | 57.0% | +35.3% |
| Operating Margin | 11.1% | -38.6% | +49.7% |
| Net Margin | 1.7% | -33.6% | +35.2% |
| FCF Margin | 3.9% | -13.9% | +17.8% |
| ROE | — | -40.4% | — |
| ROA | 0.7% | -32.0% | +32.8% |
| Current Ratio | 1.70 | 2.84 | -1.14 |
| Debt / Equity | -6.95 | 0.28 | -7.23 |